You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 22, 2025

Details for Patent: 10,933,060


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,933,060 protect, and when does it expire?

Patent 10,933,060 protects GOPRELTO and NUMBRINO and is included in two NDAs.

Summary for Patent: 10,933,060
Title:Pharmaceutical compositions and methods of using the same
Abstract: Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.
Inventor(s): Moshal; Jeffrey M. (Allentown, PA), Libman; Michael (Allentown, PA)
Assignee: GENUS LIFESCIENCES INC. (Allentown, PA)
Application Number:16/904,104
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of U.S. Patent 10,933,060

Introduction

When analyzing a U.S. patent, it is crucial to understand the scope and claims of the patent, as these elements define the invention's boundaries and the rights granted to the patent holder. This article will delve into the specifics of U.S. Patent 10,933,060, using it as a case study to explain the key concepts and tools involved in patent analysis.

What is a Patent?

A patent is a form of intellectual property that grants the patent holder exclusive rights to make, use, and sell an invention for a specified period, typically 20 years from the filing date of the patent application[2].

Patent Claims

Patent claims are the most critical part of a patent, as they define the scope of the invention. Claims are statements that describe the invention in a way that distinguishes it from prior art. There are two main types of claims: independent claims and dependent claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are broad and encompass the overall invention. For example, in U.S. Patent 10,933,060, the independent claims would outline the core aspects of the invention without relying on other claims[3].

Dependent Claims

Dependent claims refer back to and further limit an independent claim. They narrow down the scope of the invention by adding additional features or limitations. These claims are often used to protect variations or specific embodiments of the invention.

Patent Scope

The scope of a patent is determined by the claims and is a critical factor in patent quality debates. The scope can be measured using metrics such as independent claim length and independent claim count. Narrower claims are generally associated with a higher probability of grant and a shorter examination process[3].

Metrics for Measuring Patent Scope

  • Independent Claim Length: Longer claims often indicate broader and more complex inventions. However, overly broad claims can lead to issues with clarity and validity.
  • Independent Claim Count: A higher number of independent claims can indicate a broader scope, but it also increases the complexity and potential for overlap with prior art[3].

Determining Inventorship

Inventorship is another vital aspect of patent law. The true and only inventors must be listed on the patent application. Incorrect or incomplete identification of inventors can lead to the patent being invalid or unenforceable[2].

Conception and Reduction to Practice

In the U.S., invention involves two steps: conception of the idea and reduction of the idea to practice. Only those who contribute to these steps are considered inventors. Errors in inventorship can be corrected, but deceptive intent can render the patent unenforceable[2].

Searching and Analyzing Patents

To analyze a patent like U.S. Patent 10,933,060, several tools and resources are available:

Global Dossier

The Global Dossier service allows users to access file histories of related applications from participating IP Offices. This includes the patent family, dossier, classification, and citation data, as well as Office Action Indicators to identify applications with office actions[1].

Public Search Facility and PTRCs

The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) provide access to patent and trademark information. Trained staff can assist in searching and understanding patent documents[1].

Common Citation Document (CCD)

The CCD consolidates prior art cited by participating offices for the family members of a patent application, allowing users to visualize search results on a single page[1].

Patent Quality Initiatives

The USPTO has implemented several initiatives to improve patent quality, including the Enhanced Patent Quality Initiative. This involves defining patent quality consistently, reassessing examination times, and analyzing the effects of incentives on patent quality[4].

Definition of Patent Quality

Stakeholders define a quality patent as one that meets statutory requirements for novelty and clarity and would be upheld if challenged. The USPTO has developed correctness measures and compliance targets to ensure statutory compliance[4].

Tools for Clarity

While the USPTO considered requiring applicants to use claim clarity tools like glossaries or claim charts, it decided against this requirement after stakeholder feedback. However, the importance of clear and concise claim language remains a focus for ensuring patent quality[4].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address issues related to patent litigation costs and accessibility. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes[5].

Case Study: U.S. Patent 10,933,060

Overview

To analyze U.S. Patent 10,933,060, one would start by reading the abstract and the background of the invention to understand its context and purpose.

Claims Analysis

  • Independent Claims: Identify the broadest claims that define the invention.
  • Dependent Claims: Analyze how the dependent claims narrow down the scope by adding specific features or limitations.

Scope Determination

Use metrics like independent claim length and count to assess the patent's scope. Compare these metrics with industry standards and previous patents in the same field to gauge the patent's breadth and potential for validity.

Inventorship

Verify the listed inventors and ensure they are the true and only inventors of the patentable subject matter. Check for any corrections or disputes related to inventorship.

Search and Analysis Tools

Utilize the Global Dossier, Public Search Facility, and CCD to gather comprehensive information about the patent family, prior art, and office actions.

Key Takeaways

  • Patent Claims: The heart of a patent, defining the invention's scope.
  • Patent Scope: Measured by metrics like independent claim length and count.
  • Inventorship: Correct identification is crucial for patent validity.
  • Search Tools: Global Dossier, Public Search Facility, and CCD are essential for thorough analysis.
  • Patent Quality: Initiatives by the USPTO aim to ensure clarity, novelty, and statutory compliance.

FAQs

What is the significance of independent claims in a patent?

Independent claims define the broadest scope of the invention and stand alone without reference to other claims.

How is patent scope measured?

Patent scope can be measured using metrics such as independent claim length and independent claim count.

Why is correct inventorship important?

Correct inventorship is crucial because incorrect or deceptive identification can render the patent invalid or unenforceable.

What tools are available for searching and analyzing patents?

Tools include the Global Dossier, Public Search Facility, Patent and Trademark Resource Centers (PTRCs), and the Common Citation Document (CCD).

What initiatives has the USPTO taken to improve patent quality?

The USPTO has implemented the Enhanced Patent Quality Initiative, which includes defining patent quality consistently, reassessing examination times, and analyzing the effects of incentives on patent quality.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Determining Inventorship for US Patent Applications: https://agsci.oregonstate.edu/sites/agsci/files/main/research/vrc_release_inventorship-gattari.pdf
  3. Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Intellectual Property: Patent Office Should Define Quality, Reassess ...: https://www.gao.gov/products/gao-16-490
  5. U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,933,060

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Noden Pharma GOPRELTO cocaine hydrochloride SOLUTION;NASAL 209963-001 Dec 14, 2017 RX Yes Yes ⤷  Try for Free ⤷  Try for Free METHOD FOR THE INDUCTION OF LOCAL ANESTHESIA OF THE MUCOUS MEMBRANES ⤷  Try for Free
Omnivium Pharms NUMBRINO cocaine hydrochloride SOLUTION;NASAL 209575-001 Jan 10, 2020 RX Yes Yes ⤷  Try for Free ⤷  Try for Free METHOD FOR THE INDUCTION OF LOCAL ANESTHESIA PRIOR TO PERFORMING A PROCEDURE ON, THROUGH, OR ADJACENT TO THE MUCOUS MEMBRANES ⤷  Try for Free
Omnivium Pharms NUMBRINO cocaine hydrochloride SOLUTION;NASAL 209575-001 Jan 10, 2020 RX Yes Yes ⤷  Try for Free ⤷  Try for Free METHOD FOR THE INDUCTION OF LOCAL ANESTHESIA OF THE MUCOUS MEMBRANES ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.